Zobrazeno 1 - 10
of 86
pro vyhledávání: '"A M, Nadzan"'
Autor:
Mi Chen, Hediki Sato, Sovouthy Tith, Yoshiyuki Ono, Hirotaka Kashiwagi, Toshiro Kozono, Akira Ishikawa, David Wallace, Thomas Arrhenius, Alex M. Nadzan, Jie-Fei Cheng, Haruhiko Sato
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:2411-2415
The discovery and structure–activity relationship of a novel series of coumarin-based TNF-α inhibitors is described. Starting from the initial lead 1a , various derivatives were prepared surrounding the coumarin core structure to optimize the in v
Autor:
Donald Chu, Alex M. Nadzan, Anna Russell, Demin Zhou, Jie-Fei Cheng, Phoebe Yuen, Jason R.B. Dyck, Guang Yang, Steve McConnell, Gary D. Lopaschuk, Steven Brown, Miguel Barbosa, Andria Tsang, Vicki Thon, Michael Pena
Publikováno v:
Protein Expression and Purification. 34:261-269
The recombinant human malonyl-CoA decarboxylase (hMCD) was overexpressed in Escherichia coli with and without the first 39 N-terminal amino acids via a cleavable MBP-fusion construct. Proteolytic digestion using genenase I to remove the MBP-fusion ta
Autor:
Alex M. Nadzan, Marcus F. Boehm, Cesario Rm, Dardashti Laura J, Canan Koch Ss, Richard A. Heyman, Glenn Croston
Publikováno v:
Journal of Medicinal Chemistry. 42:742-750
A novel series of oxime ligands has been synthesized that displays potent, specific activation of the retinoid X receptors (RXRs). The oximes of 3-substituted (tetramethyltetrahydronaphthyl)carbonylbenzoic acids are readily available by condensation
Autor:
Karen S. Flatten, Lin Zhi, Rich A. Heyman, Susan Jeong, E. Adam Kallel, Glenn Croston, Luc J. Farmer, Alex M. Nadzan
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2747-2752
A series of potent retinoid X receptor (RXR) selective ligands were designed and prepared. The lead compound 6a, showed good binding (Kd; 3–7 nM) and transactivation (EC50; 19–24 nM) to the RXR subfamily of retinoid receptors. More importantly, a
Autor:
Glenn Croston, Susan Jeong, Luc J. Farmer, Rich A. Heyman, Karen S. Flatten, E. Adam Kallel, Alex M. Nadzan, Stacie S. Canan Koch
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2393-2398
A series of potent retinoid X receptor (RXR) selective ligands was designed and prepared. The lead compound 7a showed good binding (K i ; 20–50 nM) and transactivation (EC 50 ; 40–50 nM) to the RXR subfamily of retinoid receptors. More importantl
Autor:
Beth-Ann Badea, Chan Kou Hwang, Youssef L. Bennani, Laura J. Dar-ti, Stacie S. Canan Koch, Kristin S. Marron, Alex M. Nadzan
Publikováno v:
Tetrahedron Letters. 37:8109-8112
The treatment of bicyclic and tricyclic ketones with lithium ethynyl acetylide, followed by the addition of a catalytic amount of CSA or p-TSA, affords the corresponding exocyclic olefinic ester in good yields, and geometric ratios up to 13:1 favorin
Autor:
Ira G. Schulman, Ronald M. Evans, Glenn E. Croston, Stacie S. Canan Koch, Dardashti Laura J, Deepak S. Lala, Richard A. Heyman, Ranjan Mukherjee, A. M. Nadzan
Publikováno v:
Nature. 383:450-453
Retinoid X receptor (RXR) plays a central role in the regulation of many intracellular receptor signalling pathways and can mediate ligand-dependent transcription, acting as a homodimer or as a heterodimer. Here we identify an antagonist towards RXR
Autor:
William W. Lamph, Alex M. Nadzan, Richard A. Heyman, Deborah L. Love, Dale E. Mais, Lin Zhang, Glenn Croston, Marcus F. Boehm
Publikováno v:
Journal of Medicinal Chemistry. 39:2659-2663
Retinoic acid receptor (RAR) active retinoids have proven therapeutically useful for treating certain cancers and dermatological diseases. Herein, we describe the discovery of two new RAR active trienoic acid retinoids, (2E,4E,6E)-7-(3,5-di-tert-buty
Autor:
Chun Wel Lin, Thomas R. Miller, Alex M. Nadzan, Mark W. Holladay, James F. Kerwin, Alyssa B. O'Neill, Michael J. Bennett, Hao Bai, Michael Stashko, Jorge D. Brioni, Jeffrey W. Ralston
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:3057-3062
The development of a novel series of carbamoylamino acid benzoylpiperidides as CCK B ligands is described. Selected members of the series antagonized CCK 8 -induced calcium mobilization and showed efficacy in the mouse elevated-plus maze, a measure o
Autor:
Marcus F. Boehm, Lin Zhang, Lin Zhi, Michael R. McClurg, Elain Berger, Murriel Wagoner, Dale E. Mais, Carla M. Suto, Peter J. A. Davies, Richard A. Heyman, Alex M. Nadzan
Publikováno v:
Journal of Medicinal Chemistry. 38:3146-3155
Structural modifications of the retinoid X receptor (RXR) selective compound 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2- naphthyl)ethenyl]benzoic acid (LGD1069), which is currently in phase I/IIA clinical trials for cancer and dermatological in